GlassScriptPhysician profile
Devon Pattillo
NPI 1760892616
$24,484.57
in general payments reported to CMS, 2019-2025
27 companies · $3,293 in 2025
The $3,293 reported for 2025 was more than what 96% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,186 · 2022: $6,190 · 2023: $8,543 · 2024: $4,273 · 2025: $3,293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,150 · Travel and Lodging: $595 · Education: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,115.45 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,150.00 |
| Travel and Lodging | $595.20 |
| Education | $248.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $9,840.49 | 2021-2025 | Opzelura |
| Abbvie INC. | $3,300.40 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,865.31 | 2021-2025 | |
| Genzyme Corporation | $1,187.60 | 2021-2025 | |
| Ucb, INC. | $1,173.25 | 2021-2025 | Bimzelx, Cimzia |
| Pfizer INC. | $977.55 | 2021-2025 | |
| Janssen Biotech, INC. | $952.19 | 2021-2025 | Tremfya, Simponi Aria, Simponi |
| Leo Pharma INC. | $836.43 | 2021-2025 | Adbry, Anzupgo |
| Regeneron Healthcare Solutions, INC. | $678.18 | 2021-2025 | Dupixent |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $541.58 | 2022-2025 | Siliq, Targretin, Duobrii |
| E.R. Squibb & Sons, L.L.C. | $470.68 | 2022-2025 | Sotyktu |
| Lilly USA, LLC | $456.91 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Galderma Laboratories, L.P. | $442.70 | 2021-2025 | Nemluvio, Epsolay, Oracea |
| Dermavant Sciences, INC. | $419.86 | 2022-2024 | Vtama |
| Biofrontera INC. | $349.99 | 2021-2025 | Ameluz, Xepi, Bf-Rhodoled |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $349.47 | 2021-2025 | Winlevi |
| Mayne Pharma Commercial LLC | $124.92 | 2023 | |
| Almirall LLC | $118.29 | 2021-2024 | Seysara |
| Arcutis Biotherapeutics, INC. | $103.76 | 2023-2025 | Zoryve |
| Vyne Pharmaceuticals INC. | $77.40 | 2021 | |
| Epi Health, LLC | $53.53 | 2021 | |
| Botanix Sb INC | $36.64 | 2025 | Sofdra |
| Janssen Scientific Affairs, LLC | $35.09 | 2021 | |
| Springworks Therapeutics, INC. | $26.11 | 2025 | Gomekli |
| Organon LLC | $25.00 | 2025 | |
| Verrica Pharmaceuticals INC. | $24.30 | 2024 | Ycanth |
| Genentech USA, INC. | $16.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Pattillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.